Rybelsus (Semaglutide) for the Treatment of Type 2 Diabetes

Rybelsus is the first oral semaglutide drug approved for the treatment of type 2 diabetes in adult patients. Credit: Novo Nordisk.



  • Rybelsus
  • Rybelsus
  • Rybelsus